Page 30 - Dwight Egan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NA Proactive news snapshot: Falcon Gold, Water Tower Research, African Gold, Levitee Labs, Gevo UPDATE ... A glance at some of the day's highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive Falcon Gold Corp (TSX-V:FG, OTC:FGLDF) has applied to the TSX Venture Exchange for the approval of a warrant exercise incentive program.  The proposed program would work in conjunction with a private placement completed in July that offered 5,750,000 units priced at $0.08 each. In addition to one common share, each unit contained one ...

Author Bio Eric has been writing about stocks and finance since the mid-1990s, when he lived in Prague, Czech Republic. Over the course of a varied career, he has also been a radio newscaster, an investment banker, and a bass player in a selection of rock and roll bands. A native New Yorker, he currently lives in Los Angeles. What happened The roller-coaster-like trajectory that has been Co-Diagnostics' (NASDAQ:CODX) stock price climbed another hill on Thursday. The healthcare-testing specialist's shares closed over 21% higher on the day, due largely to news of a fres...

NA Proactive news snapshot: Snowline Gold, Endeavour Mining, Playgon Games, KULR Technology Group UPDATE … A glance at some of the day's highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive Snowline Gold Corp (CSE:SGD) (OTCPINK:SNWGF) has said that it will initiate a fully funded 2021 exploration program in the first week of June at its flagship Einarson and Rogue projects in Yukon’s metal-rich Selwyn Basin, in Canada. The Yukon territory-focused gold exploration company said that discovery-stage drilling at Einarson ...

Co-Diagnostics turns 1Q net profit of nearly $8M on strong sales of its Logix Smart COVID-19 Test Fueled by $20 million in revenue, net income was $7.9 million as compared to a net loss of $1.1 million in the prior-year quarter Looking to the second quarter, Co-Diagnostics gave revenue guidance in the range of $20 million to $22 million Co-Diagnostics Inc (NASDAQ:CODX) reported that it earned a first-quarter net profit -- versus a loss last year -- on strong sales of its Logix Smart COVID-19 Test. For the quarter ended March 31, the company said income before taxes was $9.9 mill...

Share this article SALT LAKE CITY, May 13, 2021 /PRNewswire/ -- Co-Diagnostics, Inc.  (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today financial results for the first quarter ended March 31, 2021. First-Quarter 2021 Financial Results: Strong quarterly results highlighted by revenue of $20.0 million, pre-tax income of $9.9 million, diluted EPS of $0.26 Revenue of $20.0 million, primarily due to sales of the Logix Smart™ COVID-19 Test Gross profit increased to $16.8 million, representing 83.7...